Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Integral Molecular in September, 2021 for $474,833.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43NS124421-01A1 | Phase I | 474,833 | September 20, 2021 | |||||||
A SBIR Phase II contract was awarded to Integral Molecular in September, 2018 for $1,135,533.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 9R44DK117803-02A1 | Phase II | 1,135,533 | September 7, 2018 | |||||||
A SBIR Phase II contract was awarded to Integral Molecular in April, 2020 for $585,859.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44GM112181-03 | Phase II | 585,859 | April 1, 2020 | |||||||
A SBIR Phase II contract was awarded to Integral Molecular in July, 2020 for $934,299.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44GM113556-05 | Phase II | 934,299 | July 1, 2020 | |||||||
A SBIR Phase I contract was awarded to Integral Molecular in June, 2022 for $358,588.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AG076101-01 | Phase I | 358,588 | June 1, 2022 | |||||||
A SBIR Phase II contract was awarded to Integral Molecular in June, 2022 for $599,881.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44CA265434-01A1 | Phase II | 599,881 | June 1, 2022 | |||||||
A SBIR Phase I contract was awarded to Integral Molecular for $600,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N93022C00032 | Phase I | 600,000 | ||||||||
A SBIR Phase I contract was awarded to Integral Molecular in September, 2014 for $471,745.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM112181-01 | Phase I | 471,745 | September 5, 2014 | |||||||
A SBIR Phase II contract was awarded to Integral Molecular in January, 2017 for $1,573,082.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44GM113556-02A1 | Phase II | 1,573,082 | January 10, 2017 | |||||||
A SBIR Phase II contract was awarded to Integral Molecular in September, 2014 for $1,428,459.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44GM096500-03 | Phase II | 1,428,459 | September 15, 2014 | |||||||
A SBIR Phase I contract was awarded to Integral Molecular for $214,214.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM101718-01 | Phase I | 214,214 | ||||||||
A SBIR Phase I contract was awarded to Integral Molecular for $150,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43CO200900066 | Phase I | 150,000 | ||||||||
A SBIR Phase I contract was awarded to Integral Molecular for $171,137.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R41HL075907-01 | Phase I | 171,137 | ||||||||
A SBIR Phase I contract was awarded to Integral Molecular for $242,376.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI096936-01 | Phase I | 242,376 | ||||||||
A SBIR Phase I contract was awarded to Integral Molecular for $599,243.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI079856-01 | Phase I | 599,243 | ||||||||
A SBIR Phase II contract was awarded to Integral Molecular for $1,192,920.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44GM072379-03 | Phase II | 1,192,920 | ||||||||
A SBIR Phase I contract was awarded to Integral Molecular for $222,303.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM076779-01 | Phase I | 222,303 | ||||||||
A STTR Phase II contract was awarded to Integral Molecular for $913,082.0 USD from the U.S. Department of Health & Human Services. | STTR | 2R42AI062100-03 | Phase II | 913,082 | ||||||||
A SBIR Phase I contract was awarded to Integral Molecular for $660,813.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM096500-01 | Phase I | 660,813 | ||||||||
A SBIR Phase II contract was awarded to Integral Molecular for $775,397.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44GM076779-02 | Phase II | 775,397 | ||||||||
A STTR Phase I contract was awarded to Integral Molecular for $171,137.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41HL075907-01 | Phase I | 171,137 | ||||||||
A SBIR Phase I contract was awarded to Integral Molecular for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI063693-01 | Phase I | 100,000 | ||||||||
A STTR Phase I contract was awarded to Integral Molecular for $139,885.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41HL073533-01 | Phase I | 139,885 | ||||||||
A SBIR Phase I contract was awarded to Integral Molecular for $94,374.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM064924-01 | Phase I | 94,374 | ||||||||
A SBIR Phase I contract was awarded to Integral Molecular for $94,374.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43RR016832-01 | Phase I | 94,374 |